Ambulatory Infusion Pumps in Pain Management: A Market Briefing
After years of neglect, concerns over pain, how it is assessed and managed on a patient-by-patient basis have captured the attention of health care professionals and the public. There are a variety of issues that have acted to draw this attention, including the high prevalence of pain, continuing evidence that pain is undertreated and a growing awareness of the negative consequences of poor pain management.
Infusion pumps were first introduced in the 1960s. These devices ushered in a whole new standard of care. Doctors were able to control precisely the amount of medication given to many patients. The pumps operate by controlling the fluid flow through the intravenous tubing that runs through them. Precise dosage control has been beneficial in controlling the delivery of pain medication.
This report analyzes the world markets for ambulatory infusion pumps for pain management, focusing on the current and future markets for these devices. The report generally reviews the nature and direction of research, as well as future markets.
Market size and growth for ambulatory infusion pumps generally and for ambulatory infusion pumps in pain management indications are provided for the years 2004 to 2008 for three regions: the United States, Europe, and Asia.
Epidemiology of various types of pain and key related statistics such as costs and surgery volume are also provided. This briefing also profiles several companies involved in marketing or developing such products in the field, including Alaris Medical Systems, I-Flow, Deltec, and Sgarlato Laboratories.
Market forecasts are based on an examination of current market conditions and on investigations into the development of new products by key companies. This information is also weighted with the projected timing and the probability of receiving FDA and other regulatory approval to market products. The information presented in this report is the result of data gathered from company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press. In addition, interviews were conducted with company executives, clinicians, researchers and public health officials.
- Market Drivers
- Summary of Results
CHAPTER TWO: INTRODUCTION
- Pain—A Common Ailment
- The Nature and Process of Pain
- Chronic Pain
- Impact on Daily Life
- Psychological Impact
- Impact on Worker Productivity
- Impact of Managed Care
- Pain Management and Ambulatory Care
- Minimizing Hospital Stays
- Evolution of Pain Clinics
- Increasing Demand for Ambulatory Pain Care
- Types of Pain and Epidemiology
- Types of Pain
- Common Pain Drugs
- National Hospital Ambulatory Medical Care Survey
- Managing Pain
- Trends in Management
- Cultural Issues
- Growth in Non-Hospital Recoveries
- Proactive Pain Therapy
- Standards for Assessing Pain
- Increased Responsibilities of Care Institutions
- Post-Operative Pain Management
- Assessing Individual Needs
- Ambulatory Infusion Pumps
- Critical for Therapy Delivery
CHAPTER THREE: AMBULATORY INFUSION PUMP MARKET
CHAPTER FOUR: KEY PLAYERS AND TECHNOLOGIES
- Advanced Infusion
- Alaris Medical Systems Inc.
- Baxter International Inc.
- Ipump Pain Management System
- Deltec Inc. (Smiths Medical MD, Inc.)
- I-Flow Corp.
- McKinley Medical LLLP
- Orthofix International NV
- Sgarlato Laboratories Inc.
- Sorenson Medical Inc.
- Stryker Corp.
list of exhibits
- Exhibit 1: Reasons for Growth in Ambulatory Infusion Pumps
- Exhibit 2: Types of Chronic Pain by Number of Cases and Estimated Cost, 2002
- Exhibit 3: Ambulatory Trends from the NHAMCS, 2000
- Exhibit 4: Pain Management Responsibilities of HealthCare Providers
- Exhibit 5: Statistics on Ambulatory Infusion Pumps for Postoperative Surgery Pain 2003
- Exhibit 6: U.S. Market for Ambulatory Infusion Pumps for Pain Management Indications 2004-2008
- Exhibit 7: European Market for Ambulatory Infusion Pumps for Pain Management Indications 2004-2008
- Exhibit 8: Asian Market for Ambulatory Infusion Pumps for Pain Management Indications 2004-2008